Skip to main content

Advertisement

Log in

LncRNA HOTAIR as a ceRNA is related to breast cancer risk and prognosis

  • Original Laboratory Investigation
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Purpose

Breast cancer (BC) is one of the biggest threats to women’s health. LncRNA HOTAIR is related to the recurrence and metastasis of BC. Whether HOTAIR can serve as an effective biomarker to distinguish BC patients with different prognosis need to be further studied.

Methods

The miRNA and mRNA expression profile data of BC patients were downloaded from TCGA database. Univariate Cox regression was used to screen differential expression genes (DEGs). The miRcode database and miRWalk database were used to predict miRNA binding to HOTAIR and binding sites of miRNAs, respectively. Kaplan-Meier (KM) analysis was used to estimate the overall survival rate of BC patients. Finally, qRT-PCR and western blot were applied to evaluate the expression level of HOTAIR and mRNAs between BC cells and normal mammary cells.

Results

The patients with high HOTAIR expression had poor prognosis in BC. Totally 10 genes correlated with BC prognosis were identified from 170 DEGs, among which PAX7, IYD, ZIC2, MS4A1, TPRXL, CD24, LHX1 were positively correlated with HOTAIR, while CHAD, NPY1R, TPRG1 were opposite. The levels of IYD, ZIC2, CD24 mRNA and protein were increased in BC tissues and BC cells. In BC cells, the levels of IYD, ZIC2 and CD24 mRNA and protein were significantly increased in HOTAIR overexpressed group. HOTAIR had the strongest interaction with hsa-miR-129-5p, followed by hsa-miR-107.

Conclusion

HOTAIR regulated the expression of downstream genes by interacting with 8 miRNAs and ultimately affected the prognosis of BC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

Data availability

The data that support the findings of this study are openly available in the Cancer Genome Atlas (TCGA, https://tcga-data.nci.nih.gov/tcga/).

Abbreviations

BC:

Breast cancer

lncRNAs:

Long noncoding RNAs

ceRNA:

Competitive endogenous RNA

HOTAIR:

HOX transcript antisense RNA

miRNAs:

MicroRNAs

HR:

Hazard ratio

LIHC:

Liver hepatocellular carcinoma

References

  1. Fahad Ullah M (2019) Breast Cancer: current perspectives on the Disease Status. Adv Exp Med Biol 1152:51–64

    CAS  PubMed  Google Scholar 

  2. Bray F et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424

    PubMed  Google Scholar 

  3. Peng Y et al (2021) Construction and validation of an Immune infiltration-related gene signature for the prediction of prognosis and therapeutic response in breast Cancer. Front Immunol 12:666137

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Shiyanbola O et al (2020) Long noncoding RNA expression in adrenal cortical neoplasms. Endocr Pathol 31(4):385–391

    CAS  PubMed  Google Scholar 

  5. Li T et al (2016) Molecular mechanisms of long noncoding RNAs on gastric cancer. Oncotarget 7(8):8601–8612

    PubMed  PubMed Central  Google Scholar 

  6. Ghafouri-Fard S et al (2021) HOX transcript antisense RNA: an oncogenic lncRNA in diverse malignancies. Exp Mol Pathol 118:104578

    CAS  PubMed  Google Scholar 

  7. Rinn JL et al (2007) Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129(7):1311–1323

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Kim HJ et al (2015) Long non-coding RNA HOTAIR is associated with human cervical cancer progression. Int J Oncol 46(2):521–530

    CAS  PubMed  Google Scholar 

  9. Ding W et al (2017) Long noncoding RNA HOTAIR modulates MiR-206-mediated Bcl-w signaling to facilitate cell proliferation in breast Cancer. Sci Rep 7(1):17261

    PubMed  PubMed Central  Google Scholar 

  10. Shi Y et al (2021) Current knowledge of long non-coding RNA HOTAIR in breast Cancer progression and its application. Life (Basel), 11(6)

  11. Wu D et al (2021) LncRNA HOTAIR promotes breast cancer progression through regulating the miR-129-5p/FZD7 axis. Cancer Biomark 30(2):203–212

    CAS  PubMed  Google Scholar 

  12. Collina F et al (2019) LncRNA HOTAIR up-regulation is strongly related with lymph nodes metastasis and LAR subtype of Triple negative breast Cancer. J Cancer 10(9):2018–2024

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Zhang J et al (2021) LncRNA-HOTAIR activates autophagy and promotes the imatinib resistance of gastrointestinal stromal tumor cells through a mechanism involving the miR-130a/ATG2B pathway. Cell Death Dis 12(4):367

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Huntzinger E, Izaurralde E (2011) Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 12(2):99–110

    CAS  PubMed  Google Scholar 

  15. Guo LL et al (2015) Competing endogenous RNA networks and gastric cancer. World J Gastroenterol 21(41):11680–11687

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Qi X et al (2015) ceRNA in cancer: possible functions and clinical implications. J Med Genet 52(10):710–718

    PubMed  Google Scholar 

  17. Wu Y, Qian Z (2019) Long non-coding RNAs (lncRNAs) and microRNAs regulatory pathways in the tumorigenesis and pathogenesis of glioma. Discov Med 28(153):129–138

    CAS  PubMed  Google Scholar 

  18. Zhang Y et al (2018) The prognostic value of HOTAIR for predicting long-term prognosis of patients with gastrointestinal cancers. Med (Baltim) 97(26):e11139

    Google Scholar 

  19. Chen FJ et al (2013) Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Mol Carcinog 52(11):908–915

    CAS  PubMed  Google Scholar 

  20. Ritchie ME et al (2015) Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43(7):e47

    PubMed  PubMed Central  Google Scholar 

  21. Chen S et al (2021) A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer. PLoS ONE 16(10):e0258741

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Jeggari A, Marks DS, Larsson E (2012) miRcode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics 28(15):2062–2063

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Sticht C et al (2018) miRWalk: an online resource for prediction of microRNA binding sites. PLoS ONE 13(10):e0206239

    PubMed  PubMed Central  Google Scholar 

  24. Li L, Li S (2018) Mir-205-5p inhibits cell migration and invasion in prostatic carcinoma by targeting ZEB1. Oncol Lett 16(2):1715–1721

    PubMed  PubMed Central  Google Scholar 

  25. Endo H et al (2013) Enhanced expression of long non-coding RNA HOTAIR is associated with the development of gastric cancer. PLoS ONE 8(10):e77070

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Liu Z et al (2021) Long non-coding RNA HOTAIR promotes hepatocellular carcinoma progression by regulating miR-526b-3p/DHX33 axis. Genes Genomics 43(8):857–868

    CAS  PubMed  Google Scholar 

  27. Chavez-MacGregor M et al (2017) Incorporating tumor characteristics to the american Joint Committee on Cancer breast Cancer Staging System. Oncologist 22(11):1292–1300

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Hortobagyi GN, Edge SB, Giuliano A (2018) New and important changes in the TNM staging system for breast Cancer. Am Soc Clin Oncol Educ Book 38:457–467

    PubMed  Google Scholar 

  29. Wang R et al (2019) The clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer. BMC Cancer 19(1):1091

    PubMed  PubMed Central  Google Scholar 

  30. Han Q et al (2020) Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of mir-28-5p to upregulate Rap1b expression. J Exp Clin Cancer Res 39(1):151

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Bai Y et al (2019) Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progression. J Cell Physiol 234(10):18837–18848

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Ren X et al (2021) Antioxidant gene signature impacts the Immune Infiltration and predicts the prognosis of kidney renal clear cell carcinoma. Front Genet 12:721252

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Yang H, Li G, Qiu G (2021) Bioinformatics Analysis using ATAC-seq and RNA-seq for the identification of 15 Gene Signatures Associated with the prediction of prognosis in Hepatocellular Carcinoma. Front Oncol 11:726551

    PubMed  PubMed Central  Google Scholar 

  34. Chen C et al (2021) Screening and evaluation of the role of immune genes of brain metastasis in lung adenocarcinoma progression based on the TCGA and GEO databases. J Thorac Dis 13(8):5016–5034

    PubMed  PubMed Central  Google Scholar 

  35. Fan L et al (2021) Identification of a gene set correlated with Immune Status in Ovarian Cancer by transcriptome-wide data mining. Front Mol Biosci 8:670666

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Singh MP et al (2021) Transcriptomic landscape of early age onset of colorectal cancer identifies novel genes and pathways in indian CRC patients. Sci Rep 11(1):11765

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Li Y et al (2021) Identification of potential prognostic biomarkers Associated with Cancerometastasis in skin cutaneous melanoma. Front Genet 12:687979

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Chen GY et al (2014) Siglec-G/10 in self-nonself discrimination of innate and adaptive immunity. Glycobiology 24(9):800–806

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Ni YH, Zhao X, Wang W (2020) CD24, a review of its role in Tumor diagnosis, progression and therapy. Curr Gene Ther 20(2):109–126

    CAS  PubMed  Google Scholar 

  40. Tarhriz V et al (2019) Overview of CD24 as a new molecular marker in ovarian cancer. J Cell Physiol 234(3):2134–2142

    CAS  PubMed  Google Scholar 

  41. Barkal AA et al (2019) CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature 572(7769):392–396

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Tam C et al (2019) LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent years. Appl Microbiol Biotechnol 103(12):4649–4677

    CAS  PubMed  Google Scholar 

  43. Tang XJ, Wang W, Hann SS (2019) Interactions among lncRNAs, miRNAs and mRNA in colorectal cancer. Biochimie 163:58–72

    CAS  PubMed  Google Scholar 

  44. He H et al (2020) Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma. J Exp Clin Cancer Res 39(1):159

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Zhang Y et al (2016) Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers. Oncotarget 7(39):64148–64167

    PubMed  PubMed Central  Google Scholar 

  46. Liu L et al (2018) Long non-coding RNA HOTAIR acts as a competing endogenous RNA to promote glioma progression by sponging miR-126-5p. J Cell Physiol 233(9):6822–6831

    CAS  PubMed  Google Scholar 

  47. Chiappalupi S et al (2014) Defective RAGE activity in embryonal rhabdomyosarcoma cells results in high PAX7 levels that sustain migration and invasiveness. Carcinogenesis 35(10):2382–2392

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This work was supported by the Projects of Bengbu Medical College Natural Science Foundation (grand number 2020byzd061).

Author information

Authors and Affiliations

Authors

Contributions

Liyu Qian and Li Li contributed to the study conception and design. Material preparation, data curation, analysis and validation were performed by Liyu Qian, Li Li and Shen Li. The first draft of the manuscript was written by all authors. Yu Zhu and Bing Yang edited and reviewed the manuscript. All authors read and approved the final manuscript. Yang Li and Bo Zhang made great contribution during the revision process.

Corresponding authors

Correspondence to Bo Zhang, Yu Zhu or Bing Yang.

Ethics declarations

Ethics approval and consent to participate

All experiments were approved by the medical ethics committee of the First Affiliated Hospital of Bengbu Medical College, conformed to the declaration of Helsinki, and informed consent was obtained from all subjects.

Conflict of interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Liyu Qian and Li Li contributed equally to this work.

Electronic supplementary material

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qian, L., Li, L., Li, Y. et al. LncRNA HOTAIR as a ceRNA is related to breast cancer risk and prognosis. Breast Cancer Res Treat 200, 375–390 (2023). https://doi.org/10.1007/s10549-023-06982-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-023-06982-4

Keywords

Navigation